CRIS Current Research Information System

COLECCHIA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.096
EU - Europa 4.285
AS - Asia 1.530
AF - Africa 279
SA - Sud America 11
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.211
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.080
GB - Regno Unito 1.412
IT - Italia 600
VN - Vietnam 597
SE - Svezia 580
CN - Cina 563
DE - Germania 514
UA - Ucraina 255
IN - India 245
IE - Irlanda 192
FR - Francia 191
RU - Federazione Russa 176
EE - Estonia 115
ZA - Sudafrica 113
CH - Svizzera 101
TG - Togo 65
JO - Giordania 53
CI - Costa d'Avorio 41
NG - Nigeria 39
BG - Bulgaria 34
GR - Grecia 23
BE - Belgio 21
SC - Seychelles 21
FI - Finlandia 20
JP - Giappone 16
IR - Iran 15
CA - Canada 14
PL - Polonia 11
LB - Libano 8
NL - Olanda 8
HR - Croazia 6
AU - Australia 5
CZ - Repubblica Ceca 5
HK - Hong Kong 5
AT - Austria 4
ES - Italia 4
KR - Corea 4
SG - Singapore 4
TR - Turchia 4
BR - Brasile 3
CL - Cile 3
DK - Danimarca 3
EC - Ecuador 3
IL - Israele 3
SA - Arabia Saudita 3
EU - Europa 2
MD - Moldavia 2
MM - Myanmar 2
MX - Messico 2
NZ - Nuova Zelanda 2
RO - Romania 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
ID - Indonesia 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
Totale 12.211
Salva come PNG Salva come JPEG
Città #
Southend 1.308
Fairfield 941
Chandler 606
Ashburn 492
Woodbridge 397
Houston 370
Wilmington 367
Seattle 365
Dong Ket 317
Cambridge 290
Ann Arbor 276
Princeton 266
Dublin 192
Jacksonville 152
Westminster 127
Nanjing 126
Padova 119
Bologna 109
Bern 86
Berlin 66
Lomé 65
New York 64
Saint Petersburg 62
San Diego 57
Medford 55
Amman 53
Shenyang 53
Dearborn 51
Jinan 45
Abidjan 41
Boardman 40
Abeokuta 39
Beijing 37
Hebei 37
Milan 33
Sofia 33
Nanchang 31
Bremen 30
Turin 29
Changsha 28
Tianjin 27
Jiaxing 25
Mülheim 25
Redwood City 22
Brussels 20
Helsinki 20
Mahé 20
Florence 19
Norwalk 18
Des Moines 17
Kuban 17
Falls Church 16
Mountain View 16
Hangzhou 15
Tokyo 15
Haikou 13
Ningbo 13
Guangzhou 12
Pune 12
Lanzhou 11
Frankfurt am Main 10
Leawood 10
Los Angeles 10
Monmouth Junction 10
Taiyuan 10
Taizhou 10
Torino 10
Verona 10
Kunming 9
Olalla 9
Rome 8
Zhengzhou 8
Andover 7
Ferrara 7
Groningen 7
Paris 7
Shanghai 7
Toronto 7
Washington 7
Fuzhou 6
Hanover 6
Hefei 6
Redmond 6
Zanjan 6
Augusta 5
Castelnuovo Rangone 5
London 5
Muizenberg 5
Orange 5
Teramo 5
Ardabil 4
Bühl 4
Modena 4
Moscow 4
Plauen 4
Prague 4
Athens 3
Bardineto 3
Cagliari 3
Chengdu 3
Totale 8.467
Salva come PNG Salva come JPEG
Nome #
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 209
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 202
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 201
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 187
null 179
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 171
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 165
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 160
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 160
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 154
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 153
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 150
Benign hepatic nodular lesions after treatment for childhood cancer 146
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 143
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 135
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 132
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 131
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 129
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 127
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 125
Biliary symptoms, gallbladder motility, and cholecystectomy 123
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 123
Autoimmune liver diseases in a paediatric population with coeliac disease. A 10-year single-centre experience 121
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 119
null 117
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 115
Gut Microbiota and Celiac Disease 113
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 113
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 112
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? 111
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 111
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 111
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 111
Calcolosi della colecisti complicata 110
Coeliac disease and autoimmune hepatitis: Gluten-free diet can influence liver disease outcome. 110
Breath tests with stable isotopes: have they a role in liver transplantation? 109
Bacteria flora,gas and antibiotics 109
Management of hepatic encephalopathy: focus on antibiotic therapy 109
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. 108
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 107
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 107
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. 104
null 104
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 104
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 102
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 102
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 101
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors 101
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 99
Pharmacological modulation of MRP2 in primary biliary cirrhosis 98
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation variant. Result of an open, uncontrolled , multicenter trial. 96
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 96
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 95
null 95
Persistent Fever and Abdominal Pain in a Young Woman With Budd-Chiari Syndrome 95
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 94
Gut microbiota and its pathophysiology in disease paradigms. 93
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 92
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load. 92
Safety of interferon beta treatment for chronic HCV hepatitis. 91
Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease 91
The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report 91
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 91
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. 91
Prognostic factors for hepatocellular carcinoma recurrence 90
Transient Elastography (FibroScan) Is Not Correlated with Liver Fibrosis but with Cholestasis in Patients with Long-Term Home Parenteral Nutrition 90
Calcolosi della colecisti 89
Development and application of a simple and powerful tool for nutrition and lifestyle education for the Italian general population by general practitioners and family paediatricians 89
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 89
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply. 88
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 87
H 2breath testing for other gas-related syndromes 87
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 86
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods. 86
Gut microbiota and metabolic syndrome. 86
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 86
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study 85
null 85
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference 85
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 85
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. 84
Risk factors for gallstone formation during weight loss 84
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 83
Italian consensus conference for colonic diverticulosis and diverticular disease 83
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 83
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, costipation-variant: results of a multicenter trial 82
MALDI-TOF MS protein profiling using selective extraction with derivatized cellulose and chemometric analysis: from hepatitis C to hepatocellular carcinoma 82
Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma:back to the future 82
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 81
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 80
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness. 80
Serum TUDCA/UDCA concentration profiles after TUDCA oral load: A new test for intestinal transit time and bacteria overgrowth evaluation 79
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 79
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 79
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 79
Intestinal microflora and motility in gallstones before and after cholecystectomy: any role for gallstone pathogenesis? 77
Ecosistema intestinale: aspetti fisiopatologici e terapeutici 77
Colecistosi e tumori della colecisti 76
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure 75
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 74
Totale 10.738
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.555
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019248 0 0 0 0 0 0 0 0 0 0 75 173
2019/20203.513 548 98 36 166 369 393 457 453 449 213 120 211
2020/20211.821 375 118 58 70 15 77 25 96 177 81 83 646
2021/20222.583 241 119 139 156 211 143 60 119 88 149 771 387
2022/20232.529 286 355 158 324 162 195 52 134 454 61 176 172
2023/2024598 38 114 38 72 43 150 23 51 35 31 3 0
Totale 12.523